Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer
6 January 2026
1 min read

Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer

New York, Jan 6, 2026, 08:00 EST — Premarket

  • SBRA down 0.4% premarket after Sabra names Darrin Smith chief investment officer
  • Filing shows CFO Michael Costa adds treasurer role; Smith’s base salary set at $470,000
  • Focus shifts to next quarterly results for updates on deal flow, funding costs and outlook

Shares of Sabra Health Care REIT, Inc. fell 0.4% to $19.08 in premarket trading on Tuesday after the healthcare landlord disclosed a chief investment officer transition. A regulatory filing showed Darrin Smith will also serve as secretary and executive vice president, while Chief Financial Officer Michael Costa takes on the treasurer role, effective Jan. 1. The filing said Smith’s employment agreement sets an initial annual base salary of $470,000 and outlines severance terms. 1

The change matters because the CIO job typically shapes a REIT’s deal pipeline — what it buys, sells, and how it funds growth. For dividend-focused real estate investment trusts, capital allocation can have a direct impact on cash flow and debt costs, both of which investors track closely.

Sabra’s CEO Rick Matros said the company has “a healthy pipeline of investment opportunities,” as it hands the investment brief to a long-tenured executive. Sabra owns and invests in healthcare real estate, including senior housing and skilled nursing facilities, and said Talya Nevo-Hacohen is retiring after serving as CIO. 2

Smith, 56, had served as Sabra’s executive vice president of investments since 2020, according to the filing. He previously worked at HCP Inc — now Healthpeak Properties — and earlier held roles at GE Capital Real Estate and Ernst & Young.

Other U.S. healthcare REITs were mixed in premarket trading, with Welltower and Ventas down about 1.2% each, while Healthpeak rose about 1.2%, suggesting stock-specific factors were in focus alongside broader rate sensitivity.

SBRA is trading near the top of its recent range, with StockAnalysis.com showing a 52-week span of $15.60 to $19.97. That proximity can make the shares more reactive to incremental news — and to shifts in bond yields that often sway REIT valuations. 3

But the market’s read on the shuffle may hinge less on titles and more on execution: whether Sabra can keep underwriting discipline as funding costs move and operators’ rent coverage remains under scrutiny across healthcare real estate.

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
AEVA stock jumps 25% premarket after Nvidia DRIVE Hyperion win, Omni LiDAR launch at CES 2026
Previous Story

AEVA stock jumps 25% premarket after Nvidia DRIVE Hyperion win, Omni LiDAR launch at CES 2026

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next
Next Story

AbbVie stock flat premarket after Canada OKs Maviret for acute hepatitis C — what investors watch next

Go toTop